Chaudhuri, Abhijit, Behan, Peter O · Lancet (London, England) · 2004 · DOI
Quick Summary
This review examines fatigue in various neurological diseases, including ME/CFS. The authors explain that fatigue can result from problems in muscle function (where muscles can't sustain effort) or problems in the brain and nervous system (where the brain perceives activities as requiring excessive effort). They suggest that imbalances in stress hormones and disrupted communication between key brain regions may underlie persistent fatigue.
Why It Matters
This review provides a comprehensive framework for understanding the neurobiological basis of fatigue in ME/CFS, distinguishing it from simple muscle weakness and highlighting potential roles of the hypothalamic-pituitary-adrenal axis and central nervous system dysfunction. For patients and researchers, it establishes that ME/CFS fatigue is a genuine neurological phenomenon with identifiable pathophysiological mechanisms rather than a purely psychological condition.
Observed Findings
ME/CFS is identified as one of the most disabling neurological conditions causing chronic fatigue
Central fatigue is characterized by enhanced perception of effort and limited endurance for sustained physical and mental activities
Metabolic and structural lesions disrupting basal ganglia, thalamus, limbic system, and cortical pathways are implicated in central fatigue
Relative hypocortisolaemia may sensitize the hypothalamic-pituitary-adrenal axis to development of persistent central fatigue
Fatigue contributions involve physiological, cognitive, and affective components in variable proportions
Inferred Conclusions
Central fatigue in ME/CFS involves dysfunction in interconnected brain networks rather than primary muscular failure
Hypothalamic-pituitary-adrenal axis dysfunction may play a role in the development and persistence of fatigue
Fatigue in neurological diseases is multifactorial and requires understanding of physiological, cognitive, and psychological components
Treatment approaches should be symptomatic and rehabilitative rather than curative at present
Remaining Questions
What specific molecular and structural lesions in basal ganglia and thalamic pathways drive central fatigue in ME/CFS?
What This Study Does Not Prove
As a narrative review rather than a primary research study, this work does not present new experimental data or clinical trials; it synthesizes existing knowledge and cannot definitively prove causation or establish the relative importance of proposed mechanisms. The review does not provide specific diagnostic biomarkers or validated treatment protocols for ME/CFS. It also does not clarify why some individuals develop persistent central fatigue after stress while others do not.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →